Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ULTI.OL
- Price
- -
- Stock movement up
- +0.10 (0.69%)
- Company name
- Ultimovacs ASA
- Exchange
- (OL ,
- Currency
- NOK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 49.89M
- Ent value
- -56.33M
- Price/Sales
- -
- Price/Book
- 0.26
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 22.62%
- 1 year return
- -79.17%
- 3 year return
- -73.37%
- 5 year return
- -49.47%
- 10 year return
- -
Last updated: 2025-09-05
DIVIDENDS
ULTI.OL does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.26 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.44M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -10.81 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 131.00M |
| Net receivables | 0.00 |
| Total current assets | 140.07M |
| Goodwill | 11.74M |
| Intangible assets | 61.48M |
| Property, plant and equipment | 2.49M |
| Total assets | 215.79M |
| Accounts payable | 4.08M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 12.33M |
| Total liabilities | 24.78M |
| Shareholder's equity | 191.01M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ULTI.OL | S&P500 | |
| Current price drop from All-time high | -99.10% | -8.06% |
| Highest price drop | -99.89% | -19.00% |
| Date of highest drop | 1 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -46.86% | -2.63% |
| Avg time to new high | 36 days | 6 days |
| Max time to new high | 894 days | 89 days |
COMPANY DETAILS
Marketcap
49.89M
Marketcap category
Small-cap
Description
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Employees
17
Website
Investor relations
-
SEC filings
CEO
Country
Norway
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found